Results 191 to 200 of about 116,751 (358)
A comparative trial of clonidine, propranolol and placebo in the treatment of moderate hypertension. [PDF]
P. Wilkinson, E. B. Raftery
openalex +1 more source
Appraising the visibility, relevance and impacts of clinical pharmacology
Aims Clinical pharmacology (CP) used to be a strong medical and scientific field, but during the last three decades it seems to have lost some of its appeal. We reviewed the visibility, relevance and impact of CP and clinical pharmacologists across the globe and suggest ways to strengthen the discipline to address future pharmacotherapeutic challenges.
Serge Cremers+5 more
wiley +1 more source
Homeopathy and placebo - Synonym, similar or different? [PDF]
Meissner, Karin+1 more
core +1 more source
A PLACEBO‐CONTROLLED COMPARISON OF THE SEDATIVE PROPERTIES OF THREE BENZODIAZEPINES, LORAZEPAM, FLUNITRAZEPAM AND FOSAZEPAM [PDF]
J. W. Dundee+4 more
openalex +1 more source
Aims Amlodipine poisoning is a leading cause of cardiovascular medication‐related deaths, commonly managed with high‐dose insulin (HDI) therapy. However, HDI is a vasodilator that is counterproductive in managing vasoplegia. We aim to study HDI therapy in patients with hypotension following dihydropyridine calcium channel antagonist (CCA) overdose ...
Betty S. H. Chan+3 more
wiley +1 more source
A Comparison of Betahistine Hydrochloride With Placebo for Vertebral-Basilar Insufficiency: A Double-Blind Study [PDF]
JAMES H. SPRUILL+3 more
openalex +1 more source
Abstract Aim The aim of this paper is to describe a proposal for an algorithm to guide decision making on which cohorts in early phase pharmacology trials should employ a sentinel approach, thereby standardising and harmonising practices, and improving decision making around sentinel dosing.
Jules A. A. C. Heuberger+5 more
wiley +1 more source
Aims To characterize the pharmacokinetics (PK) and PK/pharmacodynamics (PD) regarding glycosylated haemoglobin (HbA1c) lowering using the paediatric data from DINAMO and to assess differences compared with adults. Methods Population PK and PK/PD models previously developed for empagliflozin in adults and adolescents were re‐estimated in a Bayesian ...
Juliane Rascher+7 more
wiley +1 more source